100+ Free Facharzt FMH Kinder- und Jugendpsychiatrie Practice Questions
Prepare for the Facharzt FMH für Kinder- und Jugendpsychiatrie und -psychotherapie / Spécialiste FMH en psychiatrie et psychothérapie d'enfants et d'adolescents exam with instant access — no signup required.
Loading practice questions...
Explore More Swiss FMH Medical Specialist Examinations (Facharzt SIWF/FMH)
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
Key Facts: Facharzt FMH Kinder- und Jugendpsychiatrie Exam
Written + Oral
Exam Format
SGKJPP / SIWF Examination Regulations
60–90 min
Oral Colloquium
SGKJPP Examination Committee
6 Years
Postgraduate Training
SIWF Weiterbildungsprogramm
Lifetime
FMH Title Validity
Swiss Medical Association (FMH)
CHF 1,550
Exam Fee
SGKJPP Regulations
100
Practice Questions
OpenExamPrep
The Facharzt FMH Kinder- und Jugendpsychiatrie und -psychotherapie credential certifies specialist child and adolescent psychiatrists in Switzerland through SIWF and SGKJPP. Assessment comprises a written clinical case presentation and an oral-practical colloquium with video case analysis, covering neurodevelopment, mood and eating disorders, psychotherapies, psychopharmacology, and Swiss child protection law.
Sample Facharzt FMH Kinder- und Jugendpsychiatrie Practice Questions
Try these sample questions to test your Facharzt FMH Kinder- und Jugendpsychiatrie exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1An 8-year-old boy is brought to the child psychiatric clinic due to persistent inattention, motor restlessness, and impulsive behavior in both school and home environments lasting for over 18 months. His teacher reports frequent blurting out of answers, inability to wait his turn, and difficulty sustaining attention during academic tasks. Physical examination, hearing, and vision are normal. According to current European (ESCAP) guidelines and the Multiaxial Classification Scheme (MAS), which of the following is the first-line pharmacotherapeutic agent when moderate-to-severe functional impairment persists despite psychoeducation and behavioral classroom accommodations?
2A 9-year-old girl is evaluated for suspected Attention-Deficit/Hyperactivity Disorder (ADHD). Before initiating treatment with a psychostimulant such as osmotic-release oral system (OROS) methylphenidate, which pre-therapeutic baseline diagnostic assessment is mandatory according to Swiss and European clinical standards?
3A 10-year-old boy diagnosed with ADHD combined presentation has shown inadequate clinical response and severe late-afternoon rebound irritability on optimal doses of immediate-release and extended-release methylphenidate formulations. The treating child psychiatrist considers switching to lisdexamfetamine. What pharmacokinetic mechanism distinguishes lisdexamfetamine from conventional dextroamphetamine formulations?
4A 4-year-old child is referred for developmental evaluation due to absent communicative speech, lack of eye contact, failure to respond to his name, and intense repetitive lining up of toy cars. He becomes extremely distressed when daily routines are slightly altered. Which semi-structured, standardized assessment tool is considered the gold-standard direct observational instrument for diagnosing Autism Spectrum Disorder (ASD)?
5A 12-year-old boy with Autism Spectrum Disorder (level 2 support needs) presents with severe, escalating behavioral outbursts, property destruction, and severe physical aggression toward caregivers whenever tasks are demanded. Thorough behavioral functional analysis, environmental modifications (TEACCH structure), and visual communication supports have yielded insufficient improvement. Which psychotropic medications have official regulatory approval (Swissmedic / FDA) for the treatment of severe irritability and aggression associated with ASD in children and adolescents?
6A 7-year-old boy presents with frequent eye-blinking, shoulder-shrugging, and head-jerking motor movements that have been present for 14 months. Over the past 4 months, he has also developed repetitive throat-clearing and involuntary grunting sounds. The symptoms wax and wane in intensity, worsen during stress, and are preceded by an uncomfortable premonitory urge. What is the definitive diagnosis according to DSM-5-TR and ICD-11 criteria?
7Which behavioral psychotherapy modality is established by European (ESCAP) and American (AACAP) clinical guidelines as the first-line psychosocial treatment for children with Tourette Syndrome and Chronic Tic Disorders?
8A 9-year-old child with Tourette syndrome and comorbid ADHD requires pharmacotherapy because tics cause physical neck pain and severe classroom disruption, and behavioral therapy is unavailable locally. Which pharmacological agent is particularly advantageous in this clinical scenario because it treats both ADHD and tic symptoms without worsening tics?
9An 8-year-old boy of normal intelligence (WISC-V Full Scale IQ = 108) exhibits severe, persistent difficulties with word reading accuracy, slow and effortful reading rate, and poor spelling. Phonological awareness tasks show marked deficits in phonemic segmentation and blending. His vision and hearing are intact, and he has received adequate formal schooling. According to ICD-11 (code 6A03) and MAS Axis 2 classification, what is the primary diagnosis?
10A 5-year-old boy speaks fluently, spontaneously, and with age-appropriate vocabulary at home with his parents and siblings. However, for the past 6 months since enrolling in kindergarten, he has never spoken a single word to teachers or peers, instead relying on nodding or pointing. His hearing and receptive language comprehension are normal. What is the most likely psychiatric diagnosis?
About the Facharzt FMH Kinder- und Jugendpsychiatrie Exam
The Facharzt FMH für Kinder- und Jugendpsychiatrie und -psychotherapie (Specialist in Child and Adolescent Psychiatry and Psychotherapy FMH) is the Swiss Federal specialist medical title granting full independent practice rights in child and adolescent psychiatry and psychotherapy across Switzerland. Governed by the SIWF (Swiss Institute for Postgraduate and Continuous Medical Training) and the SGKJPP / SSPPEA (Swiss Society for Child and Adolescent Psychiatry and Psychotherapy), certification requires completion of a 6-year accredited postgraduate residency, comprehensive psychotherapeutic training (theory, supervision, and self-experience), submission of a scientific written clinical case study (Kasuistik), and passing a structured oral-practical colloquium with video case analysis. The curriculum encompasses neurodevelopmental disorders (ADHD, ASD, tics, learning disabilities), pediatric mood and anxiety disorders, eating disorders (anorexia nervosa, bulimia, ARFID), psychological trauma and attachment disorders, psychotic and disruptive disorders, evidence-based psychotherapy modalities (CBT, systemic family therapy, DBT-A, psychodynamic play therapy), child/adolescent psychopharmacology, and Swiss legal and child protection frameworks (KESB, Art. 314c ZGB, Fürsorgerische Unterbringung FUB Art. 426 ZGB, Urteilsfähigkeit Art. 16 ZGB). Note on format and language: While the official Swiss examination is administered in national languages (German or French) consisting of a written case presentation and oral-practical colloquium, this question bank is an English-language multiple-choice study adaptation created by OpenExamPrep—not an official SGKJPP/SIWF exam release—specifically designed to test and consolidate clinical decision-making, psychopharmacological mechanisms, therapeutic interventions, and Swiss statutory standards.
Assessment
Two-part specialty board examination: 1) Written clinical case study (detailed psychotherapeutic and psychiatric diagnostic/treatment case report adhering to scientific guidelines), and 2) Structured oral-practical examination before the SGKJPP board evaluating real-world video case vignettes, psychotherapeutic interventions, differential diagnosis, emergency management, and Swiss legal frameworks.
Time Limit
Written case portfolio preparation plus 60–90 minutes oral clinical examination
Passing Score
Formal passing grade on the written case monograph and consensus passing evaluation by the SGKJPP examination committee across all oral clinical domains
Exam Fee
SGKJPP examination fee ~CHF 1,550; SIWF title issuance fee ~CHF 1,000–2,500; postgrad psychotherapy theory/supervision ~CHF 15,000–25,000 (often subsidized by employing clinics) (Schweizerisches Institut für ärztliche Weiter- und Fortbildung (SIWF / FMH) & Schweizerische Gesellschaft für Kinder- und Jugendpsychiatrie und -psychotherapie (SGKJPP / SSPPEA))
Facharzt FMH Kinder- und Jugendpsychiatrie Exam Content Outline
Neurodevelopmental Disorders (ADHD, ASD, Tics & Learning Disabilities)
Evidence-based diagnostic criteria, neurobiology, multiaxial classification, psychometric testing (ADOS-2, ADI-R, WISC-V, Conners-3), multimodal treatment algorithms (behavioral parent training, school accommodations), and psychopharmacotherapy (methylphenidate, lisdexamfetamine, atomoxetine, guanfacine, aripiprazole) for Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Tourette syndrome/chronic tics, communication disorders, specific learning disorders (dyslexia, dyscalculia), and intellectual developmental disabilities.
Pediatric Mood, Anxiety, Obsessive-Compulsive & Stress-Related Disorders
Clinical assessment, differential diagnosis, developmental phenomenology, psychotherapy modalities (CBT, ERP, IPT-A), and pharmacotherapy (fluoxetine, sertraline, escitalopram, lithium, second-generation antipsychotics) for pediatric major depressive disorder, disruptive mood dysregulation disorder (DMDD), pediatric bipolar disorder, generalized anxiety, social phobia, panic disorder, agoraphobia, separation anxiety, selective mutism, and obsessive-compulsive disorder (OCD).
Eating Disorders, Trauma, Attachment & Somatoform Disorders
Inpatient and outpatient management of anorexia nervosa (medical stabilization, refeeding syndrome prevention, electrolyte monitoring, family-based treatment FBT), bulimia nervosa, ARFID, binge-eating disorder; assessment and evidence-based psychotherapy for acute stress disorder, PTSD, complex developmental trauma (TF-CBT, EMDR, KidNET), attachment disorders (reactive attachment disorder RAD, disinhibited social engagement disorder DSED), functional neurological disorder / conversion, somatic symptom and chronic pain disorders.
Psychotic Disorders, Personality Emergence & Substance Use Disorders
Early identification and intervention for first-episode psychosis and early-onset schizophrenia (EOS), attenuated psychosis syndrome, medical and autoimmune mimics (anti-NMDAR encephalitis, Wilson disease, 22q11.2 deletion syndrome), second-generation antipsychotic titration and metabolic/cardiac monitoring, conduct disorder (CD) and callous-unemotional traits, oppositional defiant disorder (ODD), emerging borderline and emotionally unstable personality traits in adolescence (DBT-A, MBT-A), and adolescent substance use disorders (cannabis-induced psychosis, alcohol intoxication, behavioral/gaming addictions).
Psychotherapy Modalities, Systemic Family Interventions & Pharmacotherapy Principles
Theoretical foundations and clinical application of cognitive behavioral therapy (CBT), systemic family therapy (structural and circular interventions, multi-family therapy), dialectical behavior therapy for adolescents (DBT-A), psychodynamic child and adolescent psychotherapy (play therapy, transference, defense mechanisms), behavioral parent management training (PMT, Triple P, Incredible Years), Swissmedic approval status vs off-label psychopharmacology in minors, therapeutic drug monitoring (TDM), and ECG/QTc/endocrine monitoring protocols.
Swiss Child Protection Law, Ethics, Forensic & Emergency Interventions
Swiss Civil Code (ZGB) provisions governing child protection (Kindesschutz, KESB child endangerment reporting under Art. 314c/314d ZGB, medical confidentiality Art. 321 StGB exemptions), involuntary hospitalization / Fürsorgerische Unterbringung (FUB Art. 426–439 ZGB in minors), capacity to consent / Urteilsfähigkeit (Art. 16 ZGB) and adolescent medical autonomy, acute crisis de-escalation, emergency psychopharmacology for acute agitation, assessment and safety planning for acute suicidality and non-suicidal self-injury (NSSI), and forensic assessment of child physical/sexual abuse and neglect.
How to Pass the Facharzt FMH Kinder- und Jugendpsychiatrie Exam
What You Need to Know
- Passing score: Formal passing grade on the written case monograph and consensus passing evaluation by the SGKJPP examination committee across all oral clinical domains
- Assessment: Two-part specialty board examination: 1) Written clinical case study (detailed psychotherapeutic and psychiatric diagnostic/treatment case report adhering to scientific guidelines), and 2) Structured oral-practical examination before the SGKJPP board evaluating real-world video case vignettes, psychotherapeutic interventions, differential diagnosis, emergency management, and Swiss legal frameworks.
- Time limit: Written case portfolio preparation plus 60–90 minutes oral clinical examination
- Exam fee: SGKJPP examination fee ~CHF 1,550; SIWF title issuance fee ~CHF 1,000–2,500; postgrad psychotherapy theory/supervision ~CHF 15,000–25,000 (often subsidized by employing clinics)
Keys to Passing
- Work through all 100 available questions
- Review every answer and explanation
- Track weak areas and revisit them
- Use our AI tutor for tough concepts
Facharzt FMH Kinder- und Jugendpsychiatrie Study Tips from Top Performers
Frequently Asked Questions
What is the Facharzt FMH für Kinder- und Jugendpsychiatrie und -psychotherapie title?
The Facharzt FMH für Kinder- und Jugendpsychiatrie und -psychotherapie is the federally recognized Swiss specialist medical title awarded by the SIWF / FMH. It certifies full professional competence to independently diagnose and treat psychiatric, developmental, emotional, and behavioral disorders in children, adolescents, and their families, using psychiatric, psychopharmacological, and psychotherapeutic modalities.
How is the official Swiss Child & Adolescent Psychiatry specialist examination structured?
The examination conducted by the SGKJPP / SSPPEA consists of two main components: 1) A written scientific clinical case monograph (Kasuistik) documenting the thorough assessment, differential diagnosis, evidence-based psychotherapy, and systemic management of a complex clinical case, and 2) A structured oral-practical colloquium before an expert examination committee involving video case analysis, discussion of the submitted case, and examination of broad psychiatric and psychotherapeutic knowledge.
What are the postgraduate training duration and requirements for the title?
The total training duration is 6 years of accredited residency: 4 years in child and adolescent psychiatry and psychotherapy (including inpatient and outpatient care), 1 year in adult psychiatry and psychotherapy, and 1 year in clinical somatic medicine (such as pediatrics, neurology, neuropediatrics, or internal medicine). In addition, candidates must complete 240 hours of psychotherapy theory, 150 hours of supervision, and 100 hours of self-experience (Selbsterfahrung).
What Swiss legal frameworks are essential for child and adolescent psychiatrists?
Essential legal frameworks include the Swiss Civil Code (ZGB) provisions for child protection (Kindesschutz) and reporting to KESB (Kindes- und Erwachsenenschutzbehörde) under Art. 314c ZGB, involuntary psychiatric hospitalization (Fürsorgerische Unterbringung FUB under Art. 426–439 ZGB), capacity of judgement and medical consent (Urteilsfähigkeit under Art. 16 ZGB), and medical professional confidentiality under Art. 321 StGB.
Why is this practice question bank provided in English?
While the official Swiss specialty examination is conducted in Swiss national languages (German or French), international scientific child and adolescent psychiatric literature, clinical research, psychopharmacology guidelines (ESCAP, AACAP), and diagnostic classifications are predominantly English-based. This practice bank adapts core SGKJPP and SIWF curriculum standards into 100 high-yield English-language questions.
What are the first-line psychopharmacological treatments in child and adolescent psychiatry?
For ADHD, psychostimulants (methylphenidate, lisdexamfetamine) are first-line, followed by non-stimulants (atomoxetine, guanfacine). For moderate-to-severe pediatric depression and anxiety/OCD, SSRIs (specifically fluoxetine for depression, and sertraline/fluoxetine for OCD) are first-line in combination with CBT. Second-generation antipsychotics (aripiprazole, risperidone) are approved for severe irritability in autism or early-onset schizophrenia, requiring strict metabolic and ECG monitoring.